Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities    
Net loss $ (1,147) $ (2,679)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Realized gain (loss) on marketable debt securities (2) 4
Depreciation and amortization 253 302
Lower of cost or net realizable value inventory adjustment 17
Stock-based compensation expense 679 556
Changes in operating assets and liabilities:    
Accounts receivable (1,015) 1,485
Escrow receivable 4,812 2
Inventory (696) 17
Prepaid and other assets (30) 2
Accounts payable and accrued expenses 470 170
Other liabilities 835 (272)
Net cash provided by (used in) operating activities 4,176 (413)
Cash flows from investing activities    
Issuance of secured promissory note receivable (2,974)
Purchase of marketable securities (4,317) (1,398)
Proceeds from sale of marketable debt securities 3,839 4,339
Capital expenditures (222) (185)
Net cash (used in) provided by investing activities (3,674) 2,756
Cash flows from financing activities    
Payment of dividends (2,929)
Payment of issuance costs in connection with ATM (66)
Issuance costs on unsecured convertible promissory notes (10)
Proceeds from unsecured convertible promissory notes 10,000
Net cash provided by (used in) financing activities 9,924 (2,929)
Increase (decrease) in cash and cash equivalents 10,426 (586)
Cash and cash equivalents, at the beginning of the period 434 1,554
Cash and cash equivalents, at the end of the period 10,860 968
Supplemental disclosure of non-cash investing and financing activities:    
Net unrealized gain (loss), investments in marketable debt securities $ (2) $ 18